Skip to main content
Clinical Trials/NCT01267682
NCT01267682CompletedPhase 2

Reserve For Delirium Superimposed On Dementia (DSD)

Penn State University18 sites in 1 country283 target enrollmentStarted: January 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
283
Locations
18
Primary Endpoint
Confusion Assessment Method

Study Overview

Brief Summary

The purpose of this study is to test the effectiveness of cognitively stimulating activities for resolving delirium in people with dementia.

Detailed Description

The primary aim in this RCT is to test the efficacy of Recreational Stimulation for Elders as a Vehicle to resolve DSD (RESERVE- DSD). The investigators will randomize 256 subjects, newly admitted to post acute care, to intervention (RESERVE-DSD) or control (usual care). Intervention subjects will receive 30-minute sessions of tailored cognitively stimulating recreational activities for up to 30 days. The investigators hypothesize that subjects who receive RESERVE-DSD will have: decreased severity and duration of delirium; greater gains in attention, orientation, memory, abstract thinking, and executive functioning; and greater gains in physical function compared to subjects with DSD who receive usual care. The investigators will also evaluate potential moderators of intervention efficacy (lifetime of complex mental activities and APOE status). The secondary aim is to describe the costs associated with RESERVE-DSD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • presence of delirium
  • mild to moderate cognitive impairments
  • 65 years of age or older
  • English speaking
  • community-dwelling
  • legally authorized representative available

Exclusion Criteria

  • severe vision or hearing problems
  • diagnosis of
  • major depression
  • Parkinson's with Lewy Body disease
  • Huntington's disease
  • normal pressure hydrocephalus
  • seizure disorder
  • subdural hematoma
  • head trauma
  • known structural brain abnormalities
  • acute CVA/stroke
  • acute psychiatric condition
  • life expectancy < 6 months

Outcomes

Primary Outcomes

Confusion Assessment Method

Time Frame: Averaged over 30 days or until discharge, whichever comes first

Delirium Rating Scale

Time Frame: Averaged over 30 days or until discharge, whichever comes first

Secondary Outcomes

  • Executive Function(Averaged over 30 days or until discharge, whichever comes first)
  • Physical Function(Averaged over 30 days or until discharge, whichever comes first)
  • Memory(Averaged over 30 days or until discharge, whichever comes first)
  • Abstract Thinking(Averaged over 30 days or until discharge, whichever comes first)
  • Attention(Averaged over 30 days or until discharge, whichever comes first)
  • Orientation(Averaged over 30 days or until discharge, whichever comes first)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ann Kolanowski

Professor of Nursing

Penn State University

Study Sites (18)

Loading locations...

Similar Trials